Identificación y tratamiento oportuno exitoso de hipertermia maligna
Rev. chil. anest; 52 (4), 2023
Malignant hyperthermia (MH) is an acute hypermetabolic pharmacogenetic syndrome triggered by succinylcholine and inhaled anesthetics; the prevalence of MH episodes ranges from 1:10,000 to 1:220,000 cases per administered anesthesia; there is a deregulation in intracellular calcium homeostasis generating ...
Hipertermia Maligna/etiología, Succinilcolina/efectos adversos, Hipertermia Maligna/tratamiento farmacológico, Anestesia por Inhalación/efectos adversos, Complicaciones Intraoperatorias, Dantroleno/uso terapéutico, Hipertermia Maligna/diagnóstico, Fármacos Neuromusculares Despolarizantes/efectos adversos, Relajantes Musculares Centrales/uso terapéutico